4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000247
EVP, CO & FO sold 14,000 shares at an average $456.00 ($6,384,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WAGNER CHARLES F JR · EVP, CO & FO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-03 | Sale : show line 1 in the form 10b5-1 | −7,000 | $451.00 | $3,157,000 | 44,725 | D |
| 2025-12-03 | Sale : show line 2 in the form 10b5-1 | −7,000 | $461.00 | $3,227,000 | 37,725 | D |
| Open-market sales · 14,000 sh · avg $456.00 · $6,384,000 | ||||||
Loading xslF345X05/wk-form4_1764969405.xml…